The use of autologous CAR-T cells would require KO of MHC I and II, which can be done much more efficiently with BE combined with cell sorting.242 Alternatively, one study by Sayed et al. shows the potential of modifying genetic mutations in cancer cells using base editing by correcting KRAS and TP53 mutations on cancer organoids.243. The gene discussed is TP53; the disease is cancer.